Company

Beckley Psytech

As of the edition of 20 October 2026, Beckley Psytech runs 3 drugs; it is on route A at 1 target and on route B at 0 targets.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active3
Total3

Where it needs a new molecule

Route A at 1 target, route B at 0 targets.

Three of its 1 rows, by target and route
TargetRoute
HTR2A 5-hydroxytryptamine receptor 2ARoute A

All 1 row on route A or B

In the product

1 company-target row on route A or B; 0 are not shown here, and no score is.

Where its trials are

  • Mental health: 3 trials led
  • Chemically induced: 1 trials led